U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX1013889: GSM1670908: MiSeq_PHH_H3K27ac; Homo sapiens; ChIP-Seq
1 ILLUMINA (Illumina MiSeq) run: 2M spots, 129.6M bases, 70.6Mb downloads

Submitted by: Gene Expression Omnibus (GEO)
Study: Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin conformation amenable to epigenetic manipulation
show Abstracthide Abstract
Chronic hepatitis B virus (HBV) infection affects 240 million people worldwide and is a major risk factor for liver failure and hepatocellular carcinoma. Current antiviral therapy inhibits cytoplasmic HBV genomic replication, but is not curative since it does not eliminate nuclear HBV cccDNA, the genomic form that templates viral transcription and sustains viral persistence. Novel approaches that directly target the transcriptional regulation of cccDNA would therefore be highly desirable. cccDNA is assembled with cellular histone proteins into chromatin, but little is known about the regulation of HBV chromatin by histone posttranslational modifications (PTMs). Here, using a new cccDNA ChIP-Seq approach, we report the first genome-wide maps of PTMs in cccDNA-containing chromatin from de novo infected HepG2 cells, primary human hepatocytes and from HBV infected liver tissue. We find high levels of PTMs associated with active transcription enriched at specific sites within the HBV genome, and surprisingly very low levels of PTMs linked to transcriptional repression even at silent HBV promoters. We show that transcription and active PTMs in HBV chromatin are reduced by the activation of an innate immunity pathway, and that this can be recapitulated with a small molecule epigenetic modifying agent, opening the possibility that chromatin-based regulation of cccDNA transcription could be a new therapeutic approach to chronic HBV infection. Overall design: Mapping of mutiple histone modifications in HBV cccDNA from infected HepG2 cells, primary hepatocytes and HBV infected liver tissue
Sample: MiSeq_PHH_H3K27ac
SAMN03573662 • SRS925565 • All experiments • All runs
Organism: Homo sapiens
Library:
Instrument: Illumina MiSeq
Strategy: ChIP-Seq
Source: GENOMIC
Selection: ChIP
Layout: PAIRED
Construction protocol: Cells for chromatin immunoprecipitation (ChIP) were harvested with Accutase (Millipore) and crosslinked in PBS with 1% freshly cracked formaldehyde (Pierce) for 5 min. Fixation was quenched by adding 125mM glycine final concentration for 2 min. Next cells were washed with 10ml ice cold PBS with 0.1% Triton-X 100, 0.1% NP-40, 1mM DTT 10mM sodium butyrate, 1x protease inhibitor (Roche), resuspended in 1ml of the same buffer and incubated on ice for 10min with occasional mixing. Crude nuclei were pelleted and resuspended in Mnase digestion buffer (50mM Tris pH 7.5, 4mM MgCl2, 1mM CaCl2, 10% glycerol, 10mM sodium butyrate, 1x protease inhibitor) with 600U/ml Mnase (Fermentas). Chromatin was digested for 10 min at 37°C to mainly mononucleosomes before digestion was quenched with 10mM EGTA on ice for 30min. The digested nuclei were spun at 10,000 rpm for 5min and the supernatant (S1) saved into a fresh tube. The pellet was resuspended in Mnase buffer with 10mM EGTA and 300mM NaCl and mildly sonicated on ice 4x for 10 pulses in Heat Systems W-375 sonicator at 50% duty cycle and power setting 3. The sample was spun at 10,000 rpm for 5min and the supernatant (S2) combined with the S1 fraction. S1 and S2 fraction were mixed with an equal volume of 0% sucrose buffer (50mM Tris pH 7.5, 50mM NaCl, 5mM EDTA pH 8.0, 0.01% NP-40, 10mM sodium butyrate, 1x protease inhibitor) and concentrated in a Vivaspin 4 spin column (Sartorius) with 100K cutoff membrane to ~250ul. The concentrated sample was applied to a 5-30% sucrose gradient and centrifuged in a SW41TI at 40,000rpm at 4°C for 4h. Mononucleosome-containing fractions were pooled, concentrated to ~500ul and 100ng/ul BSA added. For ChIP antibodies were prebound to 20-30ul Protein G Dynabeads (Life Technologies) on a rotator at 4°C for 2h. The following antibodies were used: 0.5ug H3K4me3 (Abcam ab8580), 2ug H3K9me3 (Abcam ab8898), 1ug H3K27me3 (Millipore 07-449), 2ug H3K36me3 (Millipore ABE435), 0.6ug H3K27ac (Abcam ab4729), 1.2ug H3K122ac (Abcam ab33309), 2ug RNA Polymerase 2 (Abcam ab817). 1ug purified mononucleosomes (for histone modifications) or 20ug of Mnase-digested chromatin (for Polymerase 2 ChIP) were diluted in 400ul ChIP dilution buffer (20mM Tris pH 8.0, 150mM NaCl, 2mM EDTA pH 8.0, 1% Triton X-100, 10mM sodium butyrate, 1x protease inhibitor), added to the bead-antibody complex and incubated on a rotator at 4°C overnight. Samples were washed in LiCl was buffer (500mM LiCl, 50mM Tris pH 8.0, 1mM EDTA pH 8.0, 1% NP-40, 0.7% sodium deoxycholate) five times and eluted in elution buffer (1% SDS, 100mM NaHCO3). The samples were decrosslinked at 65°C for 5-6h in the presence of Proteinase K (Ambion) and purified with Qiagen PCR purification columns. ChIP DNA yield was quantified using QuBit Fluorometric Quantitation (Life Technologies). 1-2ng of DNA was used to prepare sequencing libraries with the KAPA Hyper Prep Kit (KAPA Biosystems) according to the manufacturer's instructions. For indexing, 2ul of adaptors from a TruSeq ChIP Sample Preparation Kit (Illumina) were used. Libraries were amplified with 13 PCR cycles and sequenced on a HiSeq2500 instrument (Illumina) in rapid run mode with 2x33bp paired end reads. Custom designed xGen Lockdown probes (Integrated DNA Technology) of 60bp each tiling the entire HBV genome with two-fold coverage were designed and equal amounts of libraries were pooled (500-1000ng DNA total amount) and enriched for HBV DNA according to the manufacturer's xGen rapid capture protocol v2 with slight modifications: Hybridization was performed at 50°C, and 50ul Dynabeads MyOne Streptavidin C1 (Life Technologies) were used per capture reaction. Target enriched libraries were amplified with 8 PCR cycles (KAPA HIFI HotStart ReadyMix) and sequenced on a MiSeq (Illumina) with 2x33bp paired end reads.
Experiment attributes:
GEO Accession: GSM1670908
Links:
External link:
Runs: 1 run, 2M spots, 129.6M bases, 70.6Mb
Run# of Spots# of BasesSizePublished
SRR20023361,963,980129.6M70.6Mb2015-10-08

ID:
1469314

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...